Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Gjertson, DW; Cecka, JM
   Determinants of long-term survival of pediatric kidney grafts reported to the United Network for Organ Sharing kidney transplant registry
   PEDIATRIC TRANSPLANTATION
   
   D.W. Gjertson e J.M. Cecka, "Determinants of long-term survival of pediatric kidney grafts reported to the United Network for Organ Sharing kidney transplant registry", PEDIAT TRAN, 5(1), 2001, pp. 5-15
2. Balch, CM; Soong, S; Smith, T; Ross, MI; Urist, MM; Karakousis, CP; Temple, WJ; Mihm, MC; Barnhill, RL; Jewell, WR; Wanebo, HJ; Desmond, R
   Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas
   ANNALS OF SURGICAL ONCOLOGY
   
   C.M. Balch et al., "Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas", ANN SURG O, 8(2), 2001, pp. 101-108
3. Birchall, JC; Waterworth, CA; Luscombe, C; Parkins, DA; Gumbleton, M
   Statistical modelling of the formulation variables in non-viral gene delivery systems
   JOURNAL OF DRUG TARGETING
   
   J.C. Birchall et al., "Statistical modelling of the formulation variables in non-viral gene delivery systems", J DRUG TAR, 9(3), 2001, pp. 169-184
4. Moretti, S; Carli, P; Biggeri, A; Volpi, V; Pimpinelli, N
   Cohort study of metastatic melanoma patients in the Dermatology Institute of Florence 1990/1997
   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
   
   S. Moretti et al., "Cohort study of metastatic melanoma patients in the Dermatology Institute of Florence 1990/1997", J EUR A D V, 15(1), 2001, pp. 30-33
5. Peshkin, BN; DeMarco, TA; Brogan, BM; Lerman, C; Isaacs, C
   BRCA1/2 testing: Complex themes in result interpretation
   JOURNAL OF CLINICAL ONCOLOGY
   
   B.N. Peshkin et al., "BRCA1/2 testing: Complex themes in result interpretation", J CL ONCOL, 19(9), 2001, pp. 2555-2565
6. Kilbridge, KL; Weeks, JC; Sober, AJ; Haluska, FG; Slingluff, CL; Atkins, MB; Sock, DE; Kirkwood, JM; Nease, RF
   Patient preferences for adjuvant interferon alfa-2b treatment
   JOURNAL OF CLINICAL ONCOLOGY
   
   K.L. Kilbridge et al., "Patient preferences for adjuvant interferon alfa-2b treatment", J CL ONCOL, 19(3), 2001, pp. 812-823
7. Balch, CM; Soong, SJ; Gershenwald, JE; Thompson, JF; Reintgen, DS; Cascinelli, N; Urist, M; McMasters, KM; Ross, MI; Kirkwood, JM; Atkins, MB; Thompson, JA; Coit, DG; Byrd, D; Desmond, R; Zhang, YT; Liu, PY; Lyman, GH; Morabito, A
   Prognostic factors analysis of 17,600 melanoma patients: Validation of theAmerican Joint Committee on Cancer melanoma staging system
   JOURNAL OF CLINICAL ONCOLOGY
   
   C.M. Balch et al., "Prognostic factors analysis of 17,600 melanoma patients: Validation of theAmerican Joint Committee on Cancer melanoma staging system", J CL ONCOL, 19(16), 2001, pp. 3622-3634
8. Balch, CM; Buzaid, AC; Soong, SJ; Atkins, MB; Cascinelli, N; Coit, DG; Fleming, ID; Gershenwald, JE; Houghton, A; Kirkwood, JM; McMasters, KM; Mihm, MF; Morton, DL; Reintgen, DS; Ross, MI; Sober, A; Thompson, JA; Thompson, JF
   Final version of the American Joint Committee on Cancer staging system forcutaneous melanoma
   JOURNAL OF CLINICAL ONCOLOGY
   
   C.M. Balch et al., "Final version of the American Joint Committee on Cancer staging system forcutaneous melanoma", J CL ONCOL, 19(16), 2001, pp. 3635-3648
9. Charafe-Jauffret, E; Eisinger, F; Mathoulin-Portier, MP; Hassoun, J; Birnbaum, D; Sobol, H; Jacquemier, J
   PS2-expression in BRCA1-associated breast cancers
   ANTICANCER RESEARCH
   
   E. Charafe-Jauffret et al., "PS2-expression in BRCA1-associated breast cancers", ANTICANC R, 21(4B), 2001, pp. 2877-2881
10. Hoos, A; Lewis, JJ; Antonescu, CR; Dudas, ME; Leon, L; Woodruff, JM; Brennan, MF; Cordon-Cardo, C
    Characterization of molecular abnormalities in human fibroblastic neoplasms: A model for genotype-phenotype association in soft tissue tumors
    CANCER RESEARCH
    
    A. Hoos et al., "Characterization of molecular abnormalities in human fibroblastic neoplasms: A model for genotype-phenotype association in soft tissue tumors", CANCER RES, 61(7), 2001, pp. 3171-3175
11. de Bock, GH; Tollenaar, RAEM; Papelard, H; Cornelisse, CJ; Devilee, P; van de Vijver, MJ
    Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients
    BRITISH JOURNAL OF CANCER
    
    G.H. de Bock et al., "Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients", BR J CANC, 85(9), 2001, pp. 1347-1350
12. Stojadinovic, A; Hoos, A; Karpoff, HM; Leung, DHY; Antonescu, CR; Brennan, MF; Lewis, JJ
    Soft tissue tumors of the abdominal wall - Analysis of disease patterns and treatment
    ARCHIVES OF SURGERY
    
    A. Stojadinovic et al., "Soft tissue tumors of the abdominal wall - Analysis of disease patterns and treatment", ARCH SURG, 136(1), 2001, pp. 70-79
13. Busam, KJ
    Lack of relevant information for tumor staging in pathology reports of primary cutaneous melanoma
    AJCP. American journal of clinical pathology
    
    K.J. Busam, "Lack of relevant information for tumor staging in pathology reports of primary cutaneous melanoma", AM J CLIN P, 115(5), 2001, pp. 743-746
14. Chappuis, PO; Nethercot, V; Foulkes, WD
    Clinico-pathological characteristics of BRCA1-and BRCA2-related breast cancer
    SEMINARS IN SURGICAL ONCOLOGY
    
    P.O. Chappuis et al., "Clinico-pathological characteristics of BRCA1-and BRCA2-related breast cancer", SEM SURG ON, 18(4), 2000, pp. 287-295
15. Chan, AD; Essner, R; Wanek, LA; Morton, DL
    Judging the therapeutic value of lymph node dissections for melanaoma
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    
    A.D. Chan et al., "Judging the therapeutic value of lymph node dissections for melanaoma", J AM COLL S, 191(1), 2000, pp. 16-22
16. Balch, CM; Soong, SJ; Ross, MI; Urist, MM; Karakousis, CP; Temple, WJ; Mihm, MC; Barnhill, RL; Jewell, WR; Wanebo, HJ; Harrison, R
    Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm)
    ANNALS OF SURGICAL ONCOLOGY
    
    C.M. Balch et al., "Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm)", ANN SURG O, 7(2), 2000, pp. 87-97
17. Morris, JC; Ramsey, WJ; Wildner, O; Muslow, HA; Aguilar-Cordova, E; Blaese, RM
    A phase I study of intralesional administration of an adenovirus vector expressing the HSV-1 thymidine kinase gene (AdV.RSV-TK) in combination with escalating doses of ganciclovir in patients with cutaneous metastatic malignant melanoma
    HUMAN GENE THERAPY
    
    J.C. Morris et al., "A phase I study of intralesional administration of an adenovirus vector expressing the HSV-1 thymidine kinase gene (AdV.RSV-TK) in combination with escalating doses of ganciclovir in patients with cutaneous metastatic malignant melanoma", HUM GENE TH, 11(3), 2000, pp. 487-503
18. Spitler, LE; Grossbard, ML; Ernstoff, MS; Silver, G; Jacobs, M; Hayes, FA; Soong, SJ
    Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor
    JOURNAL OF CLINICAL ONCOLOGY
    
    L.E. Spitler et al., "Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor", J CL ONCOL, 18(8), 2000, pp. 1614-1621
19. Kirkwood, JM; Ibrahim, JG; Sondak, VK; Richards, J; Flaherty, LE; Ernstoff, MS; Smith, TJ; Rao, U; Steele, M; Blum, RH
    High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of Intergroup Trial E1690/S9111/C9190
    JOURNAL OF CLINICAL ONCOLOGY
    
    J.M. Kirkwood et al., "High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of Intergroup Trial E1690/S9111/C9190", J CL ONCOL, 18(12), 2000, pp. 2444-2458
20. Svanes, C
    Trends in perforated peptic ulcer: Incidence, etiology, treatment, and prognosis
    WORLD JOURNAL OF SURGERY
    
    C. Svanes, "Trends in perforated peptic ulcer: Incidence, etiology, treatment, and prognosis", WORLD J SUR, 24(3), 2000, pp. 277-283
21. King, R; Googe, PB; Mihm, MC
    Thin melanomas
    CLINICS IN LABORATORY MEDICINE
    
    R. King et al., "Thin melanomas", CLIN LAB M, 20(4), 2000, pp. 713
22. Wysocki, A; Biesiada, Z; Beben, P; Budzynski, A
    Perforated gastric ulcer
    DIGESTIVE SURGERY
    
    A. Wysocki et al., "Perforated gastric ulcer", DIGEST SURG, 17(2), 2000, pp. 132-136
23. Sillakivi, T; Lang, A; Tein, A; Peetsalu, A
    Evaluation of risk factors for mortality in surgically treated perforated peptic ulcer
    HEPATO-GASTROENTEROLOGY
    
    T. Sillakivi et al., "Evaluation of risk factors for mortality in surgically treated perforated peptic ulcer", HEP-GASTRO, 47(36), 2000, pp. 1765-1768
24. Gee, MR; Pickard, JS
    Aeromedical decision-making for aviators with malignant melanoma: An update and review
    AVIATION SPACE AND ENVIRONMENTAL MEDICINE
    
    M.R. Gee e J.S. Pickard, "Aeromedical decision-making for aviators with malignant melanoma: An update and review", AVIAT SP EN, 71(3), 2000, pp. 245-250
25. Olson, JA; Jaques, DP; Coit, DG; Hwu, WJ
    Staging work-up and posttreatment surveillance of patients with melanoma
    CLINICS IN PLASTIC SURGERY
    
    J.A. Olson et al., "Staging work-up and posttreatment surveillance of patients with melanoma", CLIN PLAST, 27(3), 2000, pp. 377
26. Ali-Salaam, P; Ariyan, S
    Lymphatic mapping and sentinel lymph node biopsies
    CLINICS IN PLASTIC SURGERY
    
    P. Ali-Salaam e S. Ariyan, "Lymphatic mapping and sentinel lymph node biopsies", CLIN PLAST, 27(3), 2000, pp. 421
27. Hanby, AM; Kelsell, DP; Potts, HW; Gillett, CE; Bishop, DT; Spurr, NK; Barnes, DM
    Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer
    INTERNATIONAL JOURNAL OF CANCER
    
    A.M. Hanby et al., "Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer", INT J CANC, 88(2), 2000, pp. 204-208
28. Baroni, G; Rigotti, C; Amir, A; Ferrigno, G; Newman, D; Pedotti, A
    Multifactorial movement analysis in weightlessness: A ground-based feasibility study
    IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT
    
    G. Baroni et al., "Multifactorial movement analysis in weightlessness: A ground-based feasibility study", IEEE INSTR, 49(3), 2000, pp. 476-482
29. Balch, CM; Buzaid, AC; Atkins, MB; Cascinelli, N; Coit, DG; Fleming, ID; Houghton, A; Kirkwood, JM; Mihm, MF; Morton, DL; Reintgen, D; Ross, MI; Sober, A; Soong, SJ; Thompson, JA; Thompson, JF; Gershenwald, JE; McMasters, KM
    A new American Joint Committee on Cancer staging system for cutaneous melanoma
    CANCER
    
    C.M. Balch et al., "A new American Joint Committee on Cancer staging system for cutaneous melanoma", CANCER, 88(6), 2000, pp. 1484-1491
30. Marghoob, AA; Koenig, K; Bittencourt, FV; Kopf, AW; Bart, RS
    Breslow thickness and Clark level in melanoma - Support for including level in pathology reports and in American Joint Committee on Cancer staging
    CANCER
    
    A.A. Marghoob et al., "Breslow thickness and Clark level in melanoma - Support for including level in pathology reports and in American Joint Committee on Cancer staging", CANCER, 88(3), 2000, pp. 589-595
31. Martin, G; Halwani, F; Shibata, H; Meterissian, S
    Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma
    CANADIAN JOURNAL OF SURGERY
    
    G. Martin et al., "Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma", CAN J SURG, 43(1), 2000, pp. 29-34
32. Curatolo, M; Kaufmann, R; Petersen-Felix, S; Arendt-Nielsen, L; Scaramozzino, P; Zbinden, AM
    Block of pinprick and cold sensation poorly correlate with relief of postoperative pain during epidural analgesia
    CLINICAL JOURNAL OF PAIN
    
    M. Curatolo et al., "Block of pinprick and cold sensation poorly correlate with relief of postoperative pain during epidural analgesia", CLIN J PAIN, 15(1), 1999, pp. 6-12
33. Seegenschmiedt, MH; Keilholz, L; Altendorf-Hofmann, A; Urban, A; Schell, H; Hohenberger, W; Sauer, R
    Palliative radiotherapy for recurrent and metastatic malignant melanoma: Prognostic factors for tumor response and long-term outcome: A 20-year experience
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    M.H. Seegenschmiedt et al., "Palliative radiotherapy for recurrent and metastatic malignant melanoma: Prognostic factors for tumor response and long-term outcome: A 20-year experience", INT J RAD O, 44(3), 1999, pp. 607-618
34. Seegenschmiedt, MH; Keilholz, L; Altendorf-Hofmann, A; Pieritz, A; Urban, A; Schell, H; Hohenberger, W; Sauer, R
    Long term results following radiation therapy of locally recurrent and metastatic malignant melanoma
    HAUTARZT
    
    M.H. Seegenschmiedt et al., "Long term results following radiation therapy of locally recurrent and metastatic malignant melanoma", HAUTARZT, 50(8), 1999, pp. 572-579
35. HOCHWALD SN; COIT DG
    ROLE OF ELECTIVE LYMPH-NODE DISSECTION IN MELANOMA
    Seminars in surgical oncology
    
    S.N. Hochwald e D.G. Coit, "ROLE OF ELECTIVE LYMPH-NODE DISSECTION IN MELANOMA", Seminars in surgical oncology, 14(4), 1998, pp. 276-282
36. KARAKOUSIS CP
    THERAPEUTIC NODE DISSECTIONS IN MALIGNANT-MELANOMA
    Seminars in surgical oncology
    
    C.P. Karakousis, "THERAPEUTIC NODE DISSECTIONS IN MALIGNANT-MELANOMA", Seminars in surgical oncology, 14(4), 1998, pp. 291-301
37. BALCH CM
    THE JOHN-WAYNE-CLINICAL-RESEARCH-LECTURE - SURGICAL-MANAGEMENT OF MELANOMA - RESULTS OF PROSPECTIVE RANDOMIZED TRIALS
    Annals of surgical oncology
    
    C.M. Balch, "THE JOHN-WAYNE-CLINICAL-RESEARCH-LECTURE - SURGICAL-MANAGEMENT OF MELANOMA - RESULTS OF PROSPECTIVE RANDOMIZED TRIALS", Annals of surgical oncology, 5(4), 1998, pp. 301-309
38. DABROWSKA DM; ELASHOFF RM; HO W; MORTON DL
    IDENTIFYING PREDICTIVE FACTORS IN MELANOMA PROGRESSION
    Oncology Reports
    
    D.M. Dabrowska et al., "IDENTIFYING PREDICTIVE FACTORS IN MELANOMA PROGRESSION", Oncology Reports, 5(3), 1998, pp. 569-575
39. KIRKWOOD JM
    SYSTEMIC ADJUVANT TREATMENT OF HIGH-RISK MELANOMA - THE ROLE OF INTERFERON-ALPHA-2B AND OTHER IMMUNOTHERAPIES
    European journal of cancer
    
    J.M. Kirkwood, "SYSTEMIC ADJUVANT TREATMENT OF HIGH-RISK MELANOMA - THE ROLE OF INTERFERON-ALPHA-2B AND OTHER IMMUNOTHERAPIES", European journal of cancer, 34, 1998, pp. 12-17
40. Kaminsky-Forrett, MC; Conroy, T; Luporsi, E; Peiffert, D; Lapeyre, M; Boissel, P; Guillemin, F; Bey, P
    Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    M.C. Kaminsky-Forrett et al., "Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer", INT J RAD O, 42(5), 1998, pp. 935-941
41. FRANC B; ROSENBERGBOURGIN M; CAILLOU B; DUTRIEUXBERGER N; FLOQUET J; HOUCKELECOMTE M; JUSTRABO E; LANGE F; LABATMOLEUR F; LEBODIC MF; PATEY M; BEAUCHET A; SAINTANDRE JP; HEJBLUM G; VIENNET G
    MEDULLARY-THYROID CARCINOMA - SEARCH FOR HISTOLOGICAL PREDICTORS OF SURVIVAL (109 PROBAND CASES ANALYSIS)
    Human pathology
    
    B. Franc et al., "MEDULLARY-THYROID CARCINOMA - SEARCH FOR HISTOLOGICAL PREDICTORS OF SURVIVAL (109 PROBAND CASES ANALYSIS)", Human pathology, 29(10), 1998, pp. 1078-1084
42. MRAZGERNHARD S; SAGEBIEL RW; KASHANISABET M; MILLER JR; LEONG SPL
    PREDICTION OF SENTINEL LYMPH-NODE MICROMETASTASIS BY HISTOLOGICAL FEATURES IN PRIMARY CUTANEOUS MALIGNANT-MELANOMA
    Archives of dermatology
    
    S. Mrazgernhard et al., "PREDICTION OF SENTINEL LYMPH-NODE MICROMETASTASIS BY HISTOLOGICAL FEATURES IN PRIMARY CUTANEOUS MALIGNANT-MELANOMA", Archives of dermatology, 134(8), 1998, pp. 983-987
43. TERHUNE MH; SWANSON N; JOHNSON TM
    USE OF CHEST RADIOGRAPHY IN THE INITIAL EVALUATION OF PATIENTS WITH LOCALIZED MELANOMA
    Archives of dermatology
    
    M.H. Terhune et al., "USE OF CHEST RADIOGRAPHY IN THE INITIAL EVALUATION OF PATIENTS WITH LOCALIZED MELANOMA", Archives of dermatology, 134(5), 1998, pp. 569-572
44. WHOOLEY BP; SHAW P; ASTROW AB; TOTH IR; WALLACK MK
    LONG-TERM SURVIVAL AFTER LOCALLY AGGRESSIVE ANORECTAL MELANOMA
    The American surgeon
    
    B.P. Whooley et al., "LONG-TERM SURVIVAL AFTER LOCALLY AGGRESSIVE ANORECTAL MELANOMA", The American surgeon, 64(3), 1998, pp. 245-251
45. TALVE LAI; COLLAN YUI; EKFORS TO
    P90 EXCEEDING RATE AS A PROGNOSTIC FACTOR PRIMARY MALIGNANT-MELANOMA OF THE SKIN - A DNA IMAGE CYTOMETRIC STUDY
    Analytical and quantitative cytology and histology
    
    L.A.I. Talve et al., "P90 EXCEEDING RATE AS A PROGNOSTIC FACTOR PRIMARY MALIGNANT-MELANOMA OF THE SKIN - A DNA IMAGE CYTOMETRIC STUDY", Analytical and quantitative cytology and histology, 19(5), 1997, pp. 393-403
46. BUZAID AC; ROSS MI; BALCH CM; SOONG SJ; MCCARTHY WH; TINOCO L; MANSFIELD P; LEE JE; BEDIKIAN A; ETON O; PLAGER C; PAPADOPOULOS N; LEGHA SS; BENJAMIN RS
    CRITICAL ANALYSIS OF THE CURRENT AMERICAN JOINT COMMITTEE ON CANCER STAGING SYSTEM FOR CUTANEOUS MELANOMA AND PROPOSAL OF A NEW STAGING SYSTEM
    Journal of clinical oncology
    
    A.C. Buzaid et al., "CRITICAL ANALYSIS OF THE CURRENT AMERICAN JOINT COMMITTEE ON CANCER STAGING SYSTEM FOR CUTANEOUS MELANOMA AND PROPOSAL OF A NEW STAGING SYSTEM", Journal of clinical oncology, 15(3), 1997, pp. 1039-1051
47. KIRKWOOD JM; RESNICK GD; COLE BF
    EFFICACY, SAFETY, AND RISK-BENEFIT ANALYSIS OF ADJUVANT INTERFERON ALFA-2B IN MELANOMA
    Seminars in oncology
    
    J.M. Kirkwood et al., "EFFICACY, SAFETY, AND RISK-BENEFIT ANALYSIS OF ADJUVANT INTERFERON ALFA-2B IN MELANOMA", Seminars in oncology, 24(1), 1997, pp. 16-23
48. AHMED I
    MALIGNANT-MELANOMA - PROGNOSTIC INDICATORS
    Mayo Clinic proceedings
    
    I. Ahmed, "MALIGNANT-MELANOMA - PROGNOSTIC INDICATORS", Mayo Clinic proceedings, 72(4), 1997, pp. 356-361
49. SAHIN S; RAO B; KOPF AW; LEE E; RIGEL DS; NOSSA R; RAHMAN IJ; WORTZEL H; MARGHOOB AA; BART RS
    PREDICTING 10-YEAR SURVIVAL OF PATIENTS WITH PRIMARY CUTANEOUS MELANOMA - CORROBORATION OF A PROGNOSTIC MODEL
    Cancer
    
    S. Sahin et al., "PREDICTING 10-YEAR SURVIVAL OF PATIENTS WITH PRIMARY CUTANEOUS MELANOMA - CORROBORATION OF A PROGNOSTIC MODEL", Cancer, 80(8), 1997, pp. 1426-1431
50. OROURKE MGE; SCHMIDT CW; OROURKE TR; ELLEM KAO
    IMMUNOTHERAPY, INCLUDING GENE-THERAPY, FOR METASTATIC MELANOMA
    Australian and New Zealand journal of surgery
    
    M.G.E. Orourke et al., "IMMUNOTHERAPY, INCLUDING GENE-THERAPY, FOR METASTATIC MELANOMA", Australian and New Zealand journal of surgery, 67(12), 1997, pp. 834-841
51. PIEPKORN M; WEINSTOCK MA; BARNHILL RL
    THEORETICAL AND EMPIRICAL ARGUMENTS IN RELATION TO ELECTIVE LYMPH-NODE DISSECTION FOR MELANOMA
    Archives of dermatology
    
    M. Piepkorn et al., "THEORETICAL AND EMPIRICAL ARGUMENTS IN RELATION TO ELECTIVE LYMPH-NODE DISSECTION FOR MELANOMA", Archives of dermatology, 133(8), 1997, pp. 995-1002
52. KIRKWOOD JM; STRAWDERMAN MH; ERNSTOFF MS; SMITH TJ; BORDEN EC; BLUM RH
    INTERFERON ALFA-2B ADJUVANT THERAPY OF HIGH-RISK RESECTED CUTANEOUS MELANOMA - THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP TRIAL EST 1684
    Journal of clinical oncology
    
    J.M. Kirkwood et al., "INTERFERON ALFA-2B ADJUVANT THERAPY OF HIGH-RISK RESECTED CUTANEOUS MELANOMA - THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP TRIAL EST 1684", Journal of clinical oncology, 14(1), 1996, pp. 7-17
53. KUNO Y; ISHIHARA K; YAMAZAKI N; MUKAI K
    CLINICAL AND PATHOLOGICAL FEATURES OF CUTANEOUS MALIGNANT-MELANOMA - A RETROSPECTIVE ANALYSIS OF 124 JAPANESE PATIENTS
    Japanese Journal of Clinical Oncology
    
    Y. Kuno et al., "CLINICAL AND PATHOLOGICAL FEATURES OF CUTANEOUS MALIGNANT-MELANOMA - A RETROSPECTIVE ANALYSIS OF 124 JAPANESE PATIENTS", Japanese Journal of Clinical Oncology, 26(3), 1996, pp. 144-151
54. BUZZELL RA; ZITELLI JA
    FAVORABLE PROGNOSTIC FACTORS IN RECURRENT AND METASTATIC MELANOMA
    Journal of the American Academy of Dermatology
    
    R.A. Buzzell e J.A. Zitelli, "FAVORABLE PROGNOSTIC FACTORS IN RECURRENT AND METASTATIC MELANOMA", Journal of the American Academy of Dermatology, 34(5), 1996, pp. 798-803
55. METCALF JS
    MELANOMA - CRITERIA FOR HISTOLOGICAL DIAGNOSIS AND ITS REPORTING
    Seminars in oncology
    
    J.S. Metcalf, "MELANOMA - CRITERIA FOR HISTOLOGICAL DIAGNOSIS AND ITS REPORTING", Seminars in oncology, 23(6), 1996, pp. 688-692
56. LIU TP; SOONG SJ
    EPIDEMIOLOGY OF MALIGNANT-MELANOMA
    The Surgical clinics of North America
    
    T.P. Liu e S.J. Soong, "EPIDEMIOLOGY OF MALIGNANT-MELANOMA", The Surgical clinics of North America, 76(6), 1996, pp. 1205
57. ROSS MI
    STAGING EVALUATION AND SURVEILLANCE FOR MELANOMA PATIENTS IN A FISCALLY RESTRICTIVE MEDICAL ENVIRONMENT - A COMMENTARY
    The Surgical clinics of North America
    
    M.I. Ross, "STAGING EVALUATION AND SURVEILLANCE FOR MELANOMA PATIENTS IN A FISCALLY RESTRICTIVE MEDICAL ENVIRONMENT - A COMMENTARY", The Surgical clinics of North America, 76(6), 1996, pp. 1423
58. RAYMOND E; HAON C; BOAZIZ C; COSTE M
    LOGISTIC-REGRESSION MODEL OF FOTEMUSTINE TOXICITY COMBINING INDEPENDENT PHASE-II STUDIES
    Cancer
    
    E. Raymond et al., "LOGISTIC-REGRESSION MODEL OF FOTEMUSTINE TOXICITY COMBINING INDEPENDENT PHASE-II STUDIES", Cancer, 78(9), 1996, pp. 1980-1987
59. BALCH CM; SOONG SJ; BARTOLUCCI AA; URIST MM; KARAKOUSIS CP; SMITH TJ; TEMPLE WJ; ROSS MI; JEWELL WR; MIHM MC; BARNHILL RL; WANEBO HJ
    EFFICACY OF AN ELECTIVE REGIONAL LYMPH-NODE DISSECTION OF 1 TO 4 MM THICK MELANOMAS FOR PATIENTS 60 YEARS OF AGE AND YOUNGER
    Annals of surgery
    
    C.M. Balch et al., "EFFICACY OF AN ELECTIVE REGIONAL LYMPH-NODE DISSECTION OF 1 TO 4 MM THICK MELANOMAS FOR PATIENTS 60 YEARS OF AGE AND YOUNGER", Annals of surgery, 224(3), 1996, pp. 255-263
60. SCHUCHTER L; SCHULTZ DJ; SYNNESTVEDT M; TROCK BJ; GUERRY D; ELDER DE; ELENITSAS R; CLARK WH; HALPERN AC
    A PROGNOSTIC MODEL FOR PREDICTING 10-YEAR SURVIVAL IN PATIENTS WITH PRIMARY MELANOMA
    Annals of internal medicine
    
    L. Schuchter et al., "A PROGNOSTIC MODEL FOR PREDICTING 10-YEAR SURVIVAL IN PATIENTS WITH PRIMARY MELANOMA", Annals of internal medicine, 125(5), 1996, pp. 369-375
61. CURATOLO M; SCARAMOZZINO P; VENUTI FS; ORLANDO A; ZBINDEN AM
    FACTORS ASSOCIATED WITH HYPOTENSION AND BRADYCARDIA AFTER EPIDURAL BLOCKADE
    Anesthesia and analgesia
    
    M. Curatolo et al., "FACTORS ASSOCIATED WITH HYPOTENSION AND BRADYCARDIA AFTER EPIDURAL BLOCKADE", Anesthesia and analgesia, 83(5), 1996, pp. 1033-1040
62. COCKERELL CJ; LYONS JH
    ELECTIVE REGIONAL LYMPH-NODE DISSECTION IN CUTANEOUS MELANOMA
    Journal of dermatological treatment
    
    C.J. Cockerell e J.H. Lyons, "ELECTIVE REGIONAL LYMPH-NODE DISSECTION IN CUTANEOUS MELANOMA", Journal of dermatological treatment, 6(2), 1995, pp. 127-134
63. CREAGAN ET; DALTON RJ; AHMANN DL; JUNG SH; MORTON RF; LANGDON RM; KUGLER J; RODRIGUE LJ
    RANDOMIZED, SURGICAL ADJUVANT CLINICAL-TRIAL OF RECOMBINANT INTERFERON ALFA-2A IN SELECTED PATIENTS WITH MALIGNANT-MELANOMA
    Journal of clinical oncology
    
    E.T. Creagan et al., "RANDOMIZED, SURGICAL ADJUVANT CLINICAL-TRIAL OF RECOMBINANT INTERFERON ALFA-2A IN SELECTED PATIENTS WITH MALIGNANT-MELANOMA", Journal of clinical oncology, 13(11), 1995, pp. 2776-2783
64. YAMAMOTO M; TAKAHASHI H; SAITOH K; HORIKOSHI T; TAKAHASHI M
    EXPRESSION OF THE P53 PROTEIN IN MALIGNANT MELANOMAS AS A PROGNOSTIC INDICATOR
    Archives of dermatological research
    
    M. Yamamoto et al., "EXPRESSION OF THE P53 PROTEIN IN MALIGNANT MELANOMAS AS A PROGNOSTIC INDICATOR", Archives of dermatological research, 287(2), 1995, pp. 146-151
65. ABBASAKOOR F; ATTWOOD SE; MCGRATH JP; STEPHENS RB
    SIMPLE CLOSURE AND FOLLOW-UP H2 RECEPTOR ANTAGONISTS FOR PERFORATED PEPTIC-ULCER - IMMEDIATE SURVIVAL AND SYMPTOMATIC OUTCOME
    Irish medical journal
    
    F. Abbasakoor et al., "SIMPLE CLOSURE AND FOLLOW-UP H2 RECEPTOR ANTAGONISTS FOR PERFORATED PEPTIC-ULCER - IMMEDIATE SURVIVAL AND SYMPTOMATIC OUTCOME", Irish medical journal, 88(6), 1995, pp. 207
66. BOOT R; THUIS H; WIETEN G
    MULTIFACTORIAL ANALYSIS OF ANTIBIOTIC-SENSITIVITY OF BORDETELLA-BRONCHISEPTICA ISOLATES FROM GUINEA-PIGS, RABBITS AND RATS
    Laboratory animals
    
    R. Boot et al., "MULTIFACTORIAL ANALYSIS OF ANTIBIOTIC-SENSITIVITY OF BORDETELLA-BRONCHISEPTICA ISOLATES FROM GUINEA-PIGS, RABBITS AND RATS", Laboratory animals, 29(1), 1995, pp. 45-49
67. SHUMATE CR; URIST MM; MADDOX WA
    MELANOMA RECURRENCE SURVEILLANCE - PATIENT OR PHYSICIAN BASED
    Annals of surgery
    
    C.R. Shumate et al., "MELANOMA RECURRENCE SURVEILLANCE - PATIENT OR PHYSICIAN BASED", Annals of surgery, 221(5), 1995, pp. 566-571
68. EVANS RA
    UNTITLED
    Journal of the American College of Surgeons
    
    R.A. Evans, "UNTITLED", Journal of the American College of Surgeons, 179(6), 1994, pp. 764-765
69. EVANS GRD; MANSON PN
    REVIEW AND CURRENT PERSPECTIVES OF CUTANEOUS MALIGNANT-MELANOMA
    Journal of the American College of Surgeons
    
    G.R.D. Evans e P.N. Manson, "REVIEW AND CURRENT PERSPECTIVES OF CUTANEOUS MALIGNANT-MELANOMA", Journal of the American College of Surgeons, 178(5), 1994, pp. 523-540
70. GOLDSHTEIN MY; GAISAROV RV; KLINGEN IY
    MATHEMATICAL-MODEL OF THE INFLUENCE OF CURRENT-CARRYING PARTS OF A POWER CONVERTER ON THE CURRENT DISTRIBUTION BETWEEN ITS BRANCHES
    ELECTRICAL TECHNOLOGY
    
    M.Y. Goldshtein et al., "MATHEMATICAL-MODEL OF THE INFLUENCE OF CURRENT-CARRYING PARTS OF A POWER CONVERTER ON THE CURRENT DISTRIBUTION BETWEEN ITS BRANCHES", ELECTRICAL TECHNOLOGY, (4), 1994, pp. 53-62
71. LYONS JH; COCKERELL CJ
    ELECTIVE LYMPH-NODE DISSECTION FOR MELANOMA
    Journal of the American Academy of Dermatology
    
    J.H. Lyons e C.J. Cockerell, "ELECTIVE LYMPH-NODE DISSECTION FOR MELANOMA", Journal of the American Academy of Dermatology, 30(3), 1994, pp. 467-480
72. ROUSSET JJ; GAUDEBOUT C; ROUSSETTHEVENOUX AM; BINELLIVILAPLANA M
    EPIDEMIOLOGIC INTERRELATIONS OF INTESTINA L PROTOZOA BY DIRECT COUNTING - STATISTICAL-ANALYSIS OF 9 471 SURVEYS IN COMPARISON WITH LITERATURE
    Bulletin de la Societe de pathologie exotique et de ses filiales
    
    J.J. Rousset et al., "EPIDEMIOLOGIC INTERRELATIONS OF INTESTINA L PROTOZOA BY DIRECT COUNTING - STATISTICAL-ANALYSIS OF 9 471 SURVEYS IN COMPARISON WITH LITERATURE", Bulletin de la Societe de pathologie exotique et de ses filiales, 87(2), 1994, pp. 112-116
73. SVANES C; LIE RT; SVANES K; LIE SA; SOREIDE O
    ADVERSE-EFFECTS OF DELAYED TREATMENT FOR PERFORATED PEPTIC-ULCER
    Annals of surgery
    
    C. Svanes et al., "ADVERSE-EFFECTS OF DELAYED TREATMENT FOR PERFORATED PEPTIC-ULCER", Annals of surgery, 220(2), 1994, pp. 168-175
74. GREEN MS; ACKERMAN AB
    THICKNESS IS NOT AN ACCURATE GAUGE OF PROGNOSIS OF PRIMARY CUTANEOUS MELANOMA
    The American journal of dermatopathology
    
    M.S. Green e A.B. Ackerman, "THICKNESS IS NOT AN ACCURATE GAUGE OF PROGNOSIS OF PRIMARY CUTANEOUS MELANOMA", The American journal of dermatopathology, 15(5), 1993, pp. 461-473
75. SVANES C; SALVESEN H; STANGELAND L; SVANES K; SOREIDE O
    PERFORATED PEPTIC-ULCER OVER 56 YEARS - TIME TRENDS IN PATIENTS AND DISEASE CHARACTERISTICS
    Gut
    
    C. Svanes et al., "PERFORATED PEPTIC-ULCER OVER 56 YEARS - TIME TRENDS IN PATIENTS AND DISEASE CHARACTERISTICS", Gut, 34(12), 1993, pp. 1666-1671
76. SIROTT MN; BAJORIN DF; WONG GYC; TAO Y; CHAPMAN PB; TEMPLETON MA; HOUGHTON AN
    PROGNOSTIC FACTORS IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA - AMULTIVARIATE-ANALYSIS
    Cancer
    
    M.N. Sirott et al., "PROGNOSTIC FACTORS IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA - AMULTIVARIATE-ANALYSIS", Cancer, 72(10), 1993, pp. 3091-3098
77. MORTON DL; DAVTYAN DG; WANEK LA; FOSHAG LJ; COCHRAN AJ
    MULTIVARIATE-ANALYSIS OF THE RELATIONSHIP BETWEEN SURVIVAL AND THE MICROSTAGE OF PRIMARY MELANOMA BY CLARK LEVEL AND BRESLOW THICKNESS
    Cancer
    
    D.L. Morton et al., "MULTIVARIATE-ANALYSIS OF THE RELATIONSHIP BETWEEN SURVIVAL AND THE MICROSTAGE OF PRIMARY MELANOMA BY CLARK LEVEL AND BRESLOW THICKNESS", Cancer, 71(11), 1993, pp. 3737-3743
78. RIZOLI SB; NETO AC; DIORIO AC; MOREIRA MAD; MANTOVANI M
    RISK OF COMPLICATION IN PERFORATED DUODENAL-ULCER OPERATIONS ACCORDING TO THE SURGICAL TECHNIQUE EMPLOYED
    The American surgeon
    
    S.B. Rizoli et al., "RISK OF COMPLICATION IN PERFORATED DUODENAL-ULCER OPERATIONS ACCORDING TO THE SURGICAL TECHNIQUE EMPLOYED", The American surgeon, 59(5), 1993, pp. 312-314